What is FOSMIQ (Fosaprepitant Dimeglumine for Injection)
FOSMIQ (Fosaprepitant Dimeglumine) for Injection is a sterile, lyophilized prodrug of aprepitant, a substance P/neurokinn-1 (NK1) receptor antagonist.
M/s SMIQ Pharma
150 mg / vial Lyophilized Injection, Single use vial
FOSMIQ is indicated in adults for use in combination with other antiemetic agents for the:
- Prevention of acute and delayed nausea and vomiting associated with highly / moderately emetogenic Cisplatin based cancer chemotherapy in adults.
For treatment related information, please consult your treating Physician.
FOSMIQ (Fosaprepitant Dimeglumine) is available as follows:
One 150 mg single dose glass vial: White to off-white lyophilized solid, Supplied as one vial carton.
Storage and handling
Store at 2°- 8° C
Protect FOSMIQ from light
Sterile lyophilized powder intravenous use only after reconstitution and dilution
How do we source the Drug?
SMIQ Pharma will assist in sourcing the drug through its efficient network, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is essential.
Contact us @ +91 7678048225 or by email firstname.lastname@example.org.